The impact of abrocitinib on vaccine-induced immune responses in adolescents with moderate-to-severe atopic dermatitis undergoing routine tetanus, diphtheria, and pertussis vaccination in phase 3 JADE TEEN

被引：0
|
作者：
Cork, Michael
Eichenfield, Lawrence
Flohr, Carsten
Bangert, Christine
Barbarot, Sebastien
Rojo, Ricardo
Chan, Gary
Zhang, Fan
Feeney, Claire
Valdez, Hernan
机构：
来源：
ALLERGY AND ASTHMA PROCEEDINGS | 2024年 / 45卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：4
相关论文
共 33 条
  • [1] The Impact of Lebrikizumab on Vaccine-Induced Immune Responses: Results from a Phase 3 Study in Adult Patients with Moderate-to-Severe Atopic Dermatitis
    Soung, Jennifer
    Laquer, Vivian
    Merola, Joseph F.
    Moore, Angela
    Elmaraghy, Hany
    Hu, Chaoran
    Piruzeli, Maria Lucia Buziqui
    Pierce, Evangeline
    Gil, Esther Garcia
    Jarell, Abel D.
    DERMATOLOGY AND THERAPY, 2024, 14 (08) : 2181 - 2193
  • [2] Lebrikizumab does not impact vaccine-induced immune responses: Results from a phase 3 study in adult patients with moderate-to-severe atopic dermatitis
    Soung, J.
    Laquer, V.
    Merola, J. F.
    Forman, S.
    Elmaraghy, H.
    Meskimen, E.
    Hu, C.
    Natalie, C.
    Pierce, E.
    Torisu-Itakura, H.
    Gil, E.
    Jarell, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (09) : B15 - B15
  • [3] Lebrikizumab does not impact vaccine-induced immune responses: results from a phase 3 study in adult patients with moderate-to-severe atopic dermatitis
    Soung, Jennifer
    Laquer, Vivian
    Merola, Joseph F.
    Forman, Seth
    Elmaraghy, Hany
    Meskimen, Eric
    Hu, Chaoran
    Natalie, Chitra R.
    Pierce, Evangeline
    Torisu-Itakura, Hitoe
    Gil, Esther Garcia
    Jarell, Abel D.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II4 - II4
  • [4] Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis The JADE TEEN Randomized Clinical Trial
    Eichenfield, Lawrence F.
    Flohr, Carsten
    Sidbury, Robert
    Siegfried, Elaine
    Szalai, Zsuzsanna
    Galus, Ryszard
    Yao, Zhirong
    Takahashi, Hidetoshi
    Barbarot, Sebastien
    Feeney, Claire
    Zhang, Fan
    DiBonaventura, Marco
    Rojo, Ricardo
    Valdez, Hernan
    Chan, Gary
    JAMA DERMATOLOGY, 2021, 157 (10) : 1165 - 1173
  • [5] Efficacy and Safety of Abrocitinib in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis (AD): Results From the Phase 3 JADE TEEN study
    Eichenfield, Lawrence
    Flohr, Carsten
    Sidbury, Robert
    Szalai, Zsuzsanna
    Galus, Ryszard
    Yao, Zhirong
    Takahashi, Hidetoshi
    Barbarot, S. Ebastien
    Feeney, Claire
    Zhang, Fan
    DiBonaventura, Marco
    Rojo, Ricardo
    Valdez, Hernan
    Chan, Gary
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB146 - AB146
  • [6] Efficacy and safety of abrocitinib in combination with topical therapy in adolescents from China with moderate-to-severe atopic dermatitis: A post hoc analysis of the JADE TEEN phase 3 trial
    Yao, Zhirong
    Xu, Aie
    He, Li
    Ding, Yangfeng
    Hu, Guohong
    Vyas, Shefali
    Wang, Bo
    Luo, Xin
    Li, Shiqi
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II23 - II24
  • [7] ABROCITINIB TREATMENT IN ADOLESCENTS AND ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: EARLY PRURITUS RESPONSES FROM PHASE 3 TRIALS JADE MONO-1 AND JADE MONO-2
    Stander, Sonja
    Yosipovitch, Gil
    Silverberg, Jonathan I.
    Simpson, Eric L.
    Sinclair, Rodney
    Su, John C.
    Kerkmann, Urs
    Gallardo, William Romero
    Valdez, Hernan
    Rojo, Ricardo
    Biswas, Pinaki
    Farooqui, Saleem A.
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 56 - 56
  • [8] Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND)
    Shi, Vivian Y.
    Bhutani, Tina
    Fonacier, Luz
    Deleuran, Mette
    Shumack, Stephen
    Valdez, Hernan
    Zhang, Fan
    Chan, Gary L.
    Cameron, Michael C.
    Yin, Natalie C.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (02) : 351 - 358
  • [9] Rapidity of Improvement in Signs/Symptoms of Moderate-to-Severe Atopic Dermatitis by Body Region with Abrocitinib in the Phase 3 JADE COMPARE Study
    Alexis, Andrew
    de Bruin-Weller, Marjolein
    Weidinger, Stephan
    Soong, Weily
    Barbarot, Sebastien
    Ionita, Ileana
    Zhang, Fan
    Valdez, Hernan
    Clibborn, Claire
    Yin, Natalie
    DERMATOLOGY AND THERAPY, 2022, 12 (03) : 771 - 785
  • [10] Rapidity of Improvement in Signs/Symptoms of Moderate-to-Severe Atopic Dermatitis by Body Region with Abrocitinib in the Phase 3 JADE COMPARE Study
    Andrew Alexis
    Marjolein de Bruin-Weller
    Stephan Weidinger
    Weily Soong
    Sebastien Barbarot
    Ileana Ionita
    Fan Zhang
    Hernan Valdez
    Claire Clibborn
    Natalie Yin
    Dermatology and Therapy, 2022, 12 : 771 - 785
1234